AstraZeneca Markets an Herbal-Based Remedy to Expand in China

(Bloomberg Businessweek) -- AstraZeneca Plc is spending big to develop cancer drugs that can sell for hundreds of thousands of dollars per patient annually. But in China, the British pharmaceutical...